vs
Side-by-side financial comparison of Dexcom (DXCM) and SM Energy Co (SM). Click either name above to swap in a different company.
Dexcom is the larger business by last-quarter revenue ($1.3B vs $704.9M, roughly 1.8× SM Energy Co). On growth, Dexcom posted the faster year-over-year revenue change (21.6% vs -17.3%). Over the past eight quarters, SM Energy Co's revenue compounded faster (12.2% CAGR vs 12.0%).
Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S.A. and manufacturing facilities in Mesa, Arizona, U.S.A.; Batu Kawan, Malaysia and Athenry, County Galway, Ireland.
SM Energy Company is a company engaged in hydrocarbon exploration. It is organized in Delaware and headquartered in Denver, Colorado.
DXCM vs SM — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.3B | $704.9M |
| Net Profit | $267.3M | — |
| Gross Margin | 62.9% | — |
| Operating Margin | 25.6% | 25.9% |
| Net Margin | 21.2% | — |
| Revenue YoY | 21.6% | -17.3% |
| Net Profit YoY | 153.6% | — |
| EPS (diluted) | $0.67 | $0.94 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $1.3B | — | ||
| Q4 25 | $1.3B | $704.9M | ||
| Q3 25 | $1.2B | $811.6M | ||
| Q2 25 | $1.2B | $792.9M | ||
| Q1 25 | $1.0B | $844.5M | ||
| Q4 24 | $1.1B | $852.0M | ||
| Q3 24 | $994.2M | $643.6M | ||
| Q2 24 | $1.0B | $634.6M |
| Q1 26 | $267.3M | — | ||
| Q4 25 | $267.3M | — | ||
| Q3 25 | $283.8M | $155.1M | ||
| Q2 25 | $179.8M | $201.7M | ||
| Q1 25 | $105.4M | $182.3M | ||
| Q4 24 | $151.7M | — | ||
| Q3 24 | $134.6M | $240.5M | ||
| Q2 24 | $143.5M | $210.3M |
| Q1 26 | 62.9% | — | ||
| Q4 25 | 62.9% | — | ||
| Q3 25 | 60.5% | — | ||
| Q2 25 | 59.5% | — | ||
| Q1 25 | 56.9% | — | ||
| Q4 24 | 58.9% | — | ||
| Q3 24 | 59.7% | — | ||
| Q2 24 | 62.4% | — |
| Q1 26 | 25.6% | — | ||
| Q4 25 | 25.6% | 25.9% | ||
| Q3 25 | 20.1% | 30.4% | ||
| Q2 25 | 18.4% | 37.2% | ||
| Q1 25 | 12.9% | 32.7% | ||
| Q4 24 | 17.0% | 33.7% | ||
| Q3 24 | 15.3% | 51.4% | ||
| Q2 24 | 15.7% | 44.0% |
| Q1 26 | 21.2% | — | ||
| Q4 25 | 21.2% | — | ||
| Q3 25 | 23.5% | 19.1% | ||
| Q2 25 | 15.5% | 25.4% | ||
| Q1 25 | 10.2% | 21.6% | ||
| Q4 24 | 13.6% | — | ||
| Q3 24 | 13.5% | 37.4% | ||
| Q2 24 | 14.3% | 33.1% |
| Q1 26 | $0.67 | — | ||
| Q4 25 | $0.67 | $0.94 | ||
| Q3 25 | $0.70 | $1.35 | ||
| Q2 25 | $0.45 | $1.76 | ||
| Q1 25 | $0.27 | $1.59 | ||
| Q4 24 | $0.37 | $1.63 | ||
| Q3 24 | $0.34 | $2.09 | ||
| Q2 24 | $0.35 | $1.82 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $917.7M | $368.0M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $2.7B | $4.8B |
| Total Assets | $6.3B | $9.3B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $917.7M | — | ||
| Q4 25 | $917.7M | $368.0M | ||
| Q3 25 | $1.8B | $162.3M | ||
| Q2 25 | $1.2B | $101.9M | ||
| Q1 25 | $904.9M | $54.0K | ||
| Q4 24 | $606.1M | — | ||
| Q3 24 | $621.2M | $1.7B | ||
| Q2 24 | $939.2M | $487.9M |
| Q1 26 | $2.7B | — | ||
| Q4 25 | $2.7B | $4.8B | ||
| Q3 25 | $2.7B | $4.7B | ||
| Q2 25 | $2.6B | $4.6B | ||
| Q1 25 | $2.3B | $4.4B | ||
| Q4 24 | $2.1B | $4.2B | ||
| Q3 24 | $2.0B | $4.1B | ||
| Q2 24 | $2.4B | $3.8B |
| Q1 26 | $6.3B | — | ||
| Q4 25 | $6.3B | $9.3B | ||
| Q3 25 | $7.5B | $9.1B | ||
| Q2 25 | $7.3B | $9.0B | ||
| Q1 25 | $6.8B | $8.8B | ||
| Q4 24 | $6.5B | $8.6B | ||
| Q3 24 | $6.4B | $8.0B | ||
| Q2 24 | $6.8B | $6.7B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $451.9M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $294.0M | $451.9M | ||
| Q3 25 | $659.9M | $505.0M | ||
| Q2 25 | $303.0M | $571.1M | ||
| Q1 25 | $183.8M | $483.0M | ||
| Q4 24 | $301.4M | $578.4M | ||
| Q3 24 | $199.5M | $452.3M | ||
| Q2 24 | $279.4M | $476.4M |
| Q1 26 | — | — | ||
| Q4 25 | $192.1M | — | ||
| Q3 25 | $579.4M | — | ||
| Q2 25 | $208.9M | — | ||
| Q1 25 | $96.8M | — | ||
| Q4 24 | $176.8M | — | ||
| Q3 24 | $88.3M | — | ||
| Q2 24 | $213.3M | — |
| Q1 26 | — | — | ||
| Q4 25 | 15.3% | — | ||
| Q3 25 | 47.9% | — | ||
| Q2 25 | 18.1% | — | ||
| Q1 25 | 9.3% | — | ||
| Q4 24 | 15.9% | — | ||
| Q3 24 | 8.9% | — | ||
| Q2 24 | 21.2% | — |
| Q1 26 | — | — | ||
| Q4 25 | 8.1% | — | ||
| Q3 25 | 6.7% | — | ||
| Q2 25 | 8.1% | — | ||
| Q1 25 | 8.4% | — | ||
| Q4 24 | 11.2% | — | ||
| Q3 24 | 11.2% | — | ||
| Q2 24 | 6.6% | — |
| Q1 26 | — | — | ||
| Q4 25 | 1.10× | — | ||
| Q3 25 | 2.33× | 3.26× | ||
| Q2 25 | 1.69× | 2.83× | ||
| Q1 25 | 1.74× | 2.65× | ||
| Q4 24 | 1.99× | — | ||
| Q3 24 | 1.48× | 1.88× | ||
| Q2 24 | 1.95× | 2.27× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
